2021 annual financial data
Lexaria Bioscience 2021 Operating margin
Direct answer
Operating margin was -786.85%.
Operating income was -5,686,852 USD and net income was -4,027,006 USD.
Operating cash flow was -3,989,678 USD.
Get free Lexaria Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 722,738 USD
- Operating income
- -5,686,852 USD
- Net income
- -4,027,006 USD
- Operating cash flow
- -3,989,678 USD